Los hispanos tienen mayor riesgo de sufrir enfermedad de Alzheimer y para el año 2060 el número de casos aumentará más que en cualquier otro grupo étnico o racial. El estudio HABS-HD en HSC es uno de los estudios de investigación más grandes en los Estados Unidos sobre envejecimiento y enfermedad de Alzheimer en hispanos.


Ayúdenos a encontrar respuestas.

Participe hoy en el Estudio de Salud y Envejecimiento del Cerebro Disparidades en Salud para hispanos. 

Teléfono: (817) 735-2963

Sin uso de medicamentos.

Imagenología y robótica de última generación.

Un equipo atento de expertos.

Reciba compensación por su tiempo.

Como participante se someterá a una entrevista comprehensiva, exámenes funcionales, extracción de sangre, y MRI y PET scan del cerebro sin costo.  Durante todo el proceso el equipo de expertos del HSC le brindará apoyo y atención personalizada.


Meet our Doctors
Alzheimer’s disease is an irreversible brain disease that slowly destroys memory skills, thinking skills and, eventually, the ability to carry out daily activities. Our team of research experts have dedicated their careers to finding solutions.

The University of North Texas Health Science Center at Fort Worth 
HSC at Fort Worth is dedicated to understanding and eliminating health disparities in Alzheimer’s disease among African Americans and Mexican Americans. The Health & Aging Brain Study – Health Disparities (HABS-HD) is the most comprehensive study of Alzheimer’s among diverse communities ever conducted. Our team studies the biology of disease within the context of social, environmental and behavioral factors because a “who you are”, “where you are from” and “your environment” are important to how you age.

Dr. Leigh Johnson, PhD
Dr. Leigh Johnson is the Associate Director of the Institute for Translational Research and an associate professor in the Departments of Pharmacology and Neuroscience and Family Medicine. Dr. Johnson is MPI of the HABS-HD ATN study which is funded by the National Institute on Aging to examine the prevalence, progression and clinical impact of cerebral and blood-based biomarkers of amyloid (A), tau (T) and neurodegeneration (N) among ethnically diverse populations. She is also the Director of the ITR Clinical Trials Core and HSC at Fort Worth site PI for the AHEAD 3-45 study. She has extensive experience with recruitment of diverse populations into research and is the Site PI of the TRC-Pad study, which is designed to establish a trial ready cohort of individuals interested in participating in AD clinical trials. Dr. Johnson’s work also examines the link between depression and cognition. She has developed and cross-validated a depressive endophenotype (DepE) of cognitive aging across multiple national and international cohorts. This work has been translated into a proof-of-concept clinical trial (The DEMO trial), which utilizes a precision medicine approach to identify those individuals more likely to benefit from antidepressant treatment for prevention of memory loss and potentially AD.

Dr. Sid O'Bryant, PhD
Dr. Sid O’Bryant is the Executive Director of the Institute for Translational Research which is dedicated to precision medicine in Alzheimer’s disease and other neurodegenerative diseases, including Down syndrome, Lewy Body disease, Parkinson’s disease, traumatic brain injury, and others. The fully translational lab has a Biomarker Core (Dr. Hall, Director), Clinical Core (Dr. Johnson, Director), Administrative Core (Dr. O’Bryant, Director) and Data Core (Dr. Johnson, Director). The lab also has a Neuroimaging Core (USC, Dr. Toga, Director). Dr. O’Bryant's multiple NIH grants focus on novel strategies for disease detection, screening into trials (therapeutic and prevention), and patient stratification for optimal treatment response. As part of this work, the lab has a strong focus on the impact of ethnicity/diversity on cognitive loss during the aging process and runs the one-of-a-kind Health & Aging Brain Study: Health Disparities (HABS-HD), which is the most comprehensive study of Alzheimer’s among diverse communities ever conducted.

With your help, we can make a powerful impact to provide care, support and research for our communities. Join the fight against Alzheimer’s by signing up for our Health & Aging Brain Study – Health Disparities today. info@healthandagingbrainstudy.com

About HSC

  • The University of North Texas Health Science Center at Fort Worth is one of the nation’s premier graduate academic medical centers, with six schools that specialize in patient-centered education, research and health care.
  • Our mission is to create solutions for a healthier community
  • We keep patients and our community at the center of our efforts in education, research and care.
  • We push the boundaries of discovery.
  • We help make sick people well and keep vigorous people healthy.
  • The Health & Aging Brain Study – Health Disparities aligns with HSC’s commitment to confront racism as a public health emergency and to reduce racial/ethnic health disparities.
Scroll to top